Clinical-stage biotechnology company Iambic Therapeutics has secured $50m in its Series B extension financing round to bolster its pipeline comprising artificial intelligence (AI)-discovered clinical oncology programmes.
Quadram Institute Bioscience and SKAN Research Trust have embarked on a collaborative project to develop new microbial therapies using advanced genetic sequencing platform.
The Department of Health – Abu Dhabi (DoH) and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have signed a second Memorandum of Understanding (MoU) to broaden their collaboration in translational research.
Global investment company Permira has entered into a definitive agreement to make a substantial investment in PharmaCord, a pharma services company.
The Department of Health (DoH) Abu Dhabi in the UAE has entered into a memorandum of understanding (MoU) with Pfizer Gulf to bolster research in areas including sickle cell disease (SCD).
Telix Pharmaceuticals has completed Biologics License Application (BLA) submission to the US Food and Drug Administration (FDA) for TLX250-CDx (Zircaix), a radiodiagnostic agent for identifying clear cell renal cell carcinoma (ccRCC) in kidney cancer patients.
Weave Bio has secured $10m in a seed funding round spearheaded by Innovation Endeavors and Magnetic Ventures.
UK-based biotechnology company ExpressionEdits has secured $13m in a seed funding round to advance the development of protein based therapies leveraging artificial intelligence (AI)-driven intronization technology.
Lucy Therapeutics (LucyTx) has secured $12.5m in additional financing round to advance the development of new treatments for Alzheimer's and Parkinson's diseases.
Venture-backed biotechnology company RevolKa has entered into a master service agreement with Daiichi Sankyo for functional proteins.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.